"We are so glad you chose Dr. Angela Yen Moore, MD and Arlington Center for Dermatology. If you would like to schedule your first appointment with us, please call us at (817) 795-7546."

During the past decade, Arlington Center for Dermatology conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 7 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arlington Center for Dermatology" #1 sponsor was "Galderma R&D" with 6 trials, followed by "Janssen Research & Development, LLC" with 5 trials sponsored, "Astellas Pharma Inc" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Cipher Pharmaceuticals Inc." with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arlington Center for Dermatology" #1 collaborator was "GlaxoSmithKline" with 1 trials as a collaborator, "Quintiles, Inc." with 1 trials as a collaborator and "Rho, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Arlington Center for Dermatology" are "Acne Vulgaris" (5 trials), "Psoriasis" (4 trials), "Rosacea" (3 trials), "Plaque Psoriasis" (2 trials) and "Atopic Dermatitis" (1 trials). Many other conditions were trialed in "Arlington Center for Dermatology" in a lesser frequency.

Most popular intervention types in "Arlington Center for Dermatology" are "Drug" (17 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Adapalene" (2 trials), "Bermekimab" (2 trials), "Guselkumab" (2 trials) and "Vehicle cream" (2 trials). Other intervention names were less common.

The vast majority of trials in "Arlington Center for Dermatology" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Arlington Center for Dermatology". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Arlington Center for Dermatology, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Arlington Center for Dermatology, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".